PharmAust Ltd
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia. Show More...
-
Website https://www.pharmaust.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.14 EUR
-
Last Updated 17-10-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 TTM Earnings Per Share AUD -0.03 -0.36 -0.16 -0.02 -0.02 -0.02 -0.010 -0.010 -0.02 -0.010 -0.010 Dividends AUD Payout Ratio % * Shares Mil 15.0 16.0 26.0 31.0 76.0 87.0 752.0 137.0 162.0 219.0 263.0 Book Value Per Share * EUR 0.05 0.14 0.07 0.04 0.05 0.03 0.02 0.02 0.02 Free Cash Flow Per Share * EUR -0.16 -0.04 -0.010 -0.02 -0.010 -0.02 -0.010 -0.010 Return on Assets % -6.09 -140.07 -220.78 -31.07 -28.92 -21.71 -49.78 -18.59 -30.47 -18.3 -19.65 Financial Leverage (Average) 1.18 1.26 1.99 2.91 1.06 1.08 1.25 1.19 1.17 1.15 1.15 Return on Equity % -7.52 -166.72 -360.96 -67.59 -32.64 -23.19 -56.66 -22.51 -35.89 -21.26 -23.75 Return on Invested Capital % -7.79 -165.2 -283.1 -64.57 -33.66 -23.58 -54.09 -20.1 -33.81 -19.83 -20.35 Interest Coverage -3.16 -103.97 -18.03 -493.32 -540.52 -97.36 -21.63 -87.94 -31.44 -22.52 Current Ratio 4.22 1.24 0.32 0.88 6.04 5.62 1.81 3.49 2.31 3.28 3.28 Quick Ratio 3.17 1.23 0.32 0.87 5.95 5.59 1.37 2.98 1.78 2.59 2.59 Debt/Equity 0.010 0.010 0.09 0.04 0.02 0.02